小金片治疗乳腺增生症的临床疗效

Abstract
Figure/Table
References
Related Citation (13)

Download: PDF (634 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the therapeutic effect of Xiaojin tablets on breast hyperplasia, and provide evidence for their clinical application.Methods A total of 97 patients with breast hyperplasia admitted to our hospital between February 2016 and May 2017 were selected in this study. The patients were divided into Xiaojin tablet group (n=60) and the control group(n=37)treated with other drugs. The size of breast nodules and the improvement of pain from baseline were compared and analyzed to evaluate the clinical effect in these two groups.Results In the tablet group, the average maximum diameter of breast nodules before treatment was (4.21±1.15)cm, but was(0.93±0.35)cm after treatment. The average VAS prior to treatment was(6.91±1.78), compared with (2.07±0.68)after treatment. In the control group, the average maximum diameter of breast nodules was(4.24±1.07)cm prior to treatment, but was (2.23±0.58)cm after treatment. The average VAS before treatment was (7.56±1.93, but was(3.88±1.41)after treatment. After treatment, the maximum diameter of breast nodules and VAS in both groups were significantly improved. Compared to the control group, the maximum diameter of breast nodules and the pain score in Xiaojin tablet group were significantly decreased, and the difference was statistically significant(P<0.05). Conclusions Xiaojin tablets are quite effective for breast hyperplasia.

Key words： Xioajin tablet breast hyperplasia Chinese patent medicine clinical effect

Received: 06 November 2017

ZTFLH:

R655.8

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XUE Lihua
	WANG Xiangdang
	XU Hong

Cite this article:

XUE Lihua,WANG Xiangdang,XU Hong. Clinical effect of Xiaojin tablets on breast hyperplasia[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2018, 29(2): 156-158.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2018/V29/I2/156

[1]	王海霞,李迎. 小金丸和蒲公英片治疗乳腺囊性增生病54例疗效观察[J].中国社区医师,2012,14(19):219-219.
[2]	冯庆菁.小金丸治疗乳腺增生症96例临床分析[J].现代中西医结合杂志,2006,15(21):2910-2912.
[3]	连小龙,韩涛. 中药抗乳腺增生作用机制研究进展[J]. 中兽医医药杂志,2017,36(3):80-82.
[4]	林旭峰,严梅娣,谢小红,等. 中医周期疗法对乳腺增生伴乳痛患者内分泌激素及症状的改善观察[J]. 中华中医药杂志,2017,35(3):745-747.
[5]	李聪聪. 中西医结合治疗乳腺增生症的疗效与护理[J]. 实用妇科内分泌杂志,2017,4(18):38-40.
[6]	李学刚. 小剂量三苯氧胺联合乳安片治疗乳腺增生症的临床效果及不良反应分析[J]. 中外医学研究,2017,15(7):148-149.
[7]	齐久梅,张素英,王刚乐,等. 不同健康宣教方式在超声引导下麦默通微创乳腺结节手术患者中的作用[J]. 武警医学,2015,26(5):536-538.
[8]	任敏利,刘宽荣. 乳腺增生不同治疗方法的疗效观察[J]. 光明中医,2017,32(2):213-214.
[9]	刘兰,王笑喆,刘瑞丽,等. 性心理干预对乳腺增生患者报告结局(PRO)的影响[J]. 中国性科学,2017,26(5):158-160.
[10]	林卫平,林加宝. 小金丸合托瑞米芬治疗乳腺小叶增生576例[J]. 浙江中西医结合杂志,2007,17(2):100-101.
[11]	魏常胜.小金片治疗乳腺增生及乳腺疼痛症的疗效观察[J].医药论坛杂志,2016,37(5):153-154.
[12]	韩登苗,路艺,刘堂明. 中医周期法治疗乳腺增生对激素水平的影响[J]. 光明中医,2017,32(17):2458-2460.
[13]	李丽蓉. 小金丸与他莫昔芬治疗乳腺增生症160例临床观察[J].中国保健营养,2012,22(4):554-554.
[14]	华燕婷. 中西医结合疗法治疗乳腺增生症的疗效观察及护理[J].用药研究,2017,10(10A):72-73.
[15]	王露. 不同方法治疗乳腺增生症的临床疗效分析[J]. 中国妇幼健康研究,2017,28(2):103-104.